Your Health, We Care
Release date: 2024-07-10 14:28:36 Recommended: 153
Ivosidenib (Tibsovo) is a potent oral IDH1 inhibitor primarily used to treat newly diagnosed adult patients aged ≥ 75 years or unable to use intensified induction chemotherapy due to comorbidities. Adult patients with recurrent or refractory AML. Used for adult patients with locally advanced or metastatic cholangiocarcinoma who have previously received treatment and carry IDH1 mutations detected by FDA approved testing methods. (This indication has not yet been approved in the Chinese market)
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended：354Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended：363Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended：423Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended：284Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended：477Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea···【more】
Recommended：295Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended：462Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended：366Release date: 2024-07-09
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the r···【more】
Recommended：67Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved nirap···【more】
Recommended：60Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved···【more】
Recommended：79Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisoca···【more】
Recommended：74Release date: 2025-12-08
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full ap···【more】
Recommended：94Release date: 2025-12-04
Primary analysis data from the randomized, double-blind, placebo-controlled phas···【more】
Recommended：90Release date: 2025-12-01
